Davangere Sugar Company Limited has approved a USD 84.95 million investment in its wholly owned foreign subsidiary, Aurevant Global Limited, marking a significant step in its international expansion strategy. The Board of Directors sanctioned the capital injection on July 25, 2026, utilizing proceeds from the recently allotted Unsecured Foreign Currency Convertible Bonds (FCCBs). This move enables Davangere Sugar Company Limited to strengthen its operational footprint in the United Kingdom, specifically targeting the ethanol and sugar products market in London.

The investment was executed pursuant to the utilization plan outlined in the FCCB offering circular dated July 03, 2026. The FCCB issue, which received in-principle approval from BSE Limited and National Stock Exchange of India Limited on June 10, 2026, was authorized by shareholders via a special resolution at the Extra-Ordinary General Meeting held on April 24, 2026. The allotment of these bonds was finalized by the board on July 09, 2026. The current transaction falls under Regulation 30 of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, and adheres to the guidelines set forth in SEBI Master Circular HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026.

Transaction Details

The capital injection involves cash consideration for the acquisition of new equity in Aurevant Global Limited. At an applied exchange rate of 1.36 GBP per USD, the USD 84.95 million investment is equivalent to approximately GBP 62.46 million. In return, Davangere Sugar will be allotted approximately 62,463,235 new Ordinary shares of GBP 1.00 each. Aurevant Global Limited, incorporated on June 04, 2026, under the Companies Act 2006, remains a wholly owned subsidiary with no prior turnover as it has yet to commence business operations.

Regulatory and Operational Framework

The investment is being undertaken under the Automatic Route in terms of the applicable provisions of the Foreign Exchange Management Act, 1999, requiring no prior governmental approval at this stage. However, the company noted that it will obtain any subsequent approvals if required by changing regulatory circumstances. The indicative timeline for completing the necessary procedures under the Overseas Direct Investment framework is within 10 days. Since Aurevant Global Limited is an existing wholly owned subsidiary, the transaction does not constitute a related-party transaction involving external promoters or group companies outside the consolidated structure.

What the Numbers Show

The immediate deployment of nearly 85% of the maximum permissible FCCB proceeds (USD 100 million) into a single newly incorporated entity highlights a concentrated strategic bet on the UK market. By channeling funds directly into Aurevant Global Limited, which operates in the same line of business as the parent company, Davangere Sugar aims to replicate its domestic success in ethanol and sugar products internationally. The use of a fixed exchange rate of 1.36 GBP per USD for this valuation provides clarity on the capital base established in London, shielding the initial accounting entry from immediate currency volatility while setting a clear benchmark for future performance evaluation in the region.

Davangere Sugar Company has scheduled a meeting of its Board of Directors for Tuesday, July 28, 2026, to consider a proposal for raising funds. The company aims to issue convertible warrants and/or other eligible securities through private placement, preferential issue, or other permissible modes. This capital raise is intended to support the company’s financial requirements, with the specific structure and tranches to be determined by the Board.

The proposal is being considered pursuant to Regulation 29(1)(d) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The issuance will be conducted in accordance with the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, and the Companies Act, 2013, along with applicable rules.

The fund-raising exercise is subject to necessary statutory, regulatory, and other approvals. Crucially, the transaction requires the approval of the shareholders of Davangere Sugar Company Limited. The Board may decide to execute the issuance in one or more tranches, depending on market conditions and capital needs.

Key Details

S. S. Ganesh, Managing Director of Davangere Sugar Company Limited, signed the intimation letter dispatched to the stock exchanges on July 23, 2026. The company is listed on both the Bombay Stock Exchange (BSE) and the National Stock Exchange of India Limited (NSE).

What the Numbers Show

While no specific financial figures were disclosed in the intimation, the decision to raise funds through convertible warrants suggests a strategic approach to capital structure management. Convertible instruments allow the company to raise equity capital without immediate dilution, deferring conversion until future dates based on predefined terms. This method is often employed to balance immediate liquidity needs with long-term shareholder value preservation, particularly in capital-intensive sectors like sugar manufacturing where working capital cycles can be volatile. The reliance on private placement or preferential issues indicates that the company may be targeting specific institutional investors rather than conducting a broad public offering.